Information communicated to a practitioner in an effort unlawfully to procure a controlled drug, or unlawfully to procure the administration of any such drug, shall not be deemed a privileged communication.
RSA 318-B:21
1969, 421:1. 1983, 292:18, eff. Aug. 17, 1983.